Scientific Founder and Advisory Board Member

Dr. Daniel Anderson

Dr. Daniel Anderson is the Sam Goldblith Associate Professor at the Massachusetts Institute of Technology (MIT). He is appointed in chemical engineering, the Institute for Medical Engineering and Science, and the Harvard-MIT Division of Health Science and Technology. He is also an intramural member of the Koch Institute for Integrative Cancer Research at MIT. Daniel’s lab focuses on developing new materials for medicine, and he has pioneered the use of robotic methods for the development of smart biomaterials for drug delivery and tissue engineering. The advanced drug delivery systems developed in his laboratory have provided new methods for nanoparticulate and microparticulate drug delivery, non-viral gene therapy, siRNA delivery and vaccines. He has published more than 230 papers, patents and patent applications, which have led to a number of licenses to pharmaceutical, chemical and biotechnology companies. Daniel received a Ph.D. in Molecular Genetics from the University of California at Davis and a B.A. in Mathematics and Biology from the University of California at Santa Cruz.

Previous Next

You are now leaving the CRISPR Therapeutics website.

CRISPR Therapeutics is not responsible for the content or availability of third-party sites.